These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26530119)

  • 1. [Non-invasive prenatal testing: challenges for future implementation].
    Henneman L; Page-Chrisiaens GC; Oepkes D
    Ned Tijdschr Geneeskd; 2015; 159():A9479. PubMed ID: 26530119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands.
    van der Meij KRM; Sistermans EA; Macville MVE; Stevens SJC; Bax CJ; Bekker MN; Bilardo CM; Boon EMJ; Boter M; Diderich KEM; de Die-Smulders CEM; Duin LK; Faas BHW; Feenstra I; Haak MC; Hoffer MJV; den Hollander NS; Hollink IHIM; Jehee FS; Knapen MFCM; Kooper AJA; van Langen IM; Lichtenbelt KD; Linskens IH; van Maarle MC; Oepkes D; Pieters MJ; Schuring-Blom GH; Sikkel E; Sikkema-Raddatz B; Smeets DFCM; Srebniak MI; Suijkerbuijk RF; Tan-Sindhunata GM; van der Ven AJEM; van Zelderen-Bhola SL; Henneman L; Galjaard RH; Van Opstal D; Weiss MM;
    Am J Hum Genet; 2019 Dec; 105(6):1091-1101. PubMed ID: 31708118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol.
    Hill M; Wright D; Daley R; Lewis C; McKay F; Mason S; Lench N; Howarth A; Boustred C; Lo K; Plagnol V; Spencer K; Fisher J; Kroese M; Morris S; Chitty LS
    BMC Pregnancy Childbirth; 2014 Jul; 14():229. PubMed ID: 25027965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new era in prenatal care: non-invasive prenatal testing in Switzerland.
    Manegold-Brauer G; Kang Bellin A; Hahn S; De Geyter C; Buechel J; Hoesli I; Lapaire O
    Swiss Med Wkly; 2014 Feb; 144():w13915. PubMed ID: 24549748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis.
    Taylor-Phillips S; Freeman K; Geppert J; Agbebiyi A; Uthman OA; Madan J; Clarke A; Quenby S; Clarke A
    BMJ Open; 2016 Jan; 6(1):e010002. PubMed ID: 26781507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive prenatal testing for aneuploidy: current status and future prospects.
    Benn P; Cuckle H; Pergament E
    Ultrasound Obstet Gynecol; 2013 Jul; 42(1):15-33. PubMed ID: 23765643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part II-women's perspectives.
    van Schendel RV; Page-Christiaens GC; Beulen L; Bilardo CM; de Boer MA; Coumans AB; Faas BH; van Langen IM; Lichtenbelt KD; van Maarle MC; Macville MV; Oepkes D; Pajkrt E; Henneman L;
    Prenat Diagn; 2016 Dec; 36(12):1091-1098. PubMed ID: 27739584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part I-clinical impact.
    Oepkes D; Page-Christiaens GC; Bax CJ; Bekker MN; Bilardo CM; Boon EM; Schuring-Blom GH; Coumans AB; Faas BH; Galjaard RH; Go AT; Henneman L; Macville MV; Pajkrt E; Suijkerbuijk RF; Huijsdens-van Amsterdam K; Van Opstal D; Verweij EJ; Weiss MM; Sistermans EA;
    Prenat Diagn; 2016 Dec; 36(12):1083-1090. PubMed ID: 27750376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
    Audibert F; Gagnon A; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis.
    Beulen L; Grutters JP; Faas BH; Feenstra I; van Vugt JM; Bekker MN
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():53-61. PubMed ID: 25238658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in timing of prenatal diagnosis and abortion for fetal chromosomal abnormalities.
    Hume H; Chasen ST
    Am J Obstet Gynecol; 2015 Oct; 213(4):545.e1-4. PubMed ID: 26070711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
    Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive prenatal screening for trisomy 21: what women want and are willing to pay.
    Verweij EJ; Oepkes D; de Vries M; van den Akker ME; van den Akker ES; de Boer MA
    Patient Educ Couns; 2013 Dec; 93(3):641-5. PubMed ID: 24011429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of non-invasive prenatal testing within a national UK antenatal screening programme: Impact on women's choices.
    Bowden B; de Souza S; Puchades A; Williams K; Morgan S; Anderson S; Tucker D; Hillier S
    Prenat Diagn; 2022 May; 42(5):549-556. PubMed ID: 35278232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined first trimester screening and cell-free fetal DNA - “next generation screening”].
    Kagan KO; Eiben B; Kozlowski P
    Ultraschall Med; 2014 Jun; 35(3):229-36. PubMed ID: 24764214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.
    McLennan A; Palma-Dias R; da Silva Costa F; Meagher S; Nisbet DL; Scott F
    Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):22-8. PubMed ID: 26817523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening.
    Wagner AJ; Mitchell ME; Tomita-Mitchell A
    Clin Perinatol; 2014 Dec; 41(4):957-66. PubMed ID: 25459783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on key techniques and intervention in reducing birth defects].
    Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantages and Disadvantages of Different Implementation Strategies of Non-Invasive Prenatal Testing in Down Syndrome Screening Programmes.
    Mersy E; de Die-Smulders CE; Coumans AB; Smits LJ; de Wert GM; Frints SG; Veltman JA
    Public Health Genomics; 2015; 18(5):260-71. PubMed ID: 26202817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.